Volume 9 Number 11/12 November/December 2008
28 December 2008. Related: Editorial.
2008
i-BASE APPEAL
28 December 2008. Related: Editorial.
48th Annual International Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 25-28 October 2008, Washington DC
27 December 2008. Related: Conference reports.
Antiretroviral Pregnancy Registry finds no increase in congenital anomalies with exposure to tenofovir
27 December 2008. Related: Conference reports, Pregnancy.
No association between maternal antiretrovirals in pregnancy and congenital anomalies
27 December 2008. Related: Conference reports, Pregnancy.
Pharmacokinetics of saquinavir/ritonavir in pregnancy
27 December 2008. Related: Conference reports, Pregnancy.
Course of labour in pregnant HIV-positive women with no contraindication for vaginal delivery
27 December 2008. Related: Conference reports, Pregnancy.
Four weeks of antiretroviral prophylaxis is sufficient for HIV-exposed infants
27 December 2008. Related: Conference reports, Pregnancy.
HAART suppresses genital tract HIV shedding in HIV/HSV co-infected women
27 December 2008. Related: Conference reports, Women's health.
Efavirenz significantly reduces levels of some oral contraceptives
27 December 2008. Related: Conference reports, Women's health.
Lack of efficacy of isoniazid (INH) prophylaxis and PK evaluation in South African infants
27 December 2008. Related: Conference reports, Paediatric care, TB coinfection.
48-week data for darunavir/ritonavir (DRV/r) in treatment-experienced children and adolescents
26 December 2008. Related: Conference reports, Paediatric care.
Greater lipodystrophy risk in older US children with low viral load
26 December 2008. Related: Conference reports, Paediatric care.
Studies of pipeline drugs: RDEA806, PRO140, bevirimat, elvucitabine
26 December 2008. Related: Conference reports, Antiretrovirals.
Maraviroc trial results reanalysed using more sensitive CCR5 tropism test
26 December 2008. Related: Conference reports.
Other antiretroviral studies at ICAAC
26 December 2008. Related: Conference reports, Antiretrovirals.
High rate of rash in HIV negative volunteers combining raltegravir and darunavir
26 December 2008. Related: Conference reports, Side effects.
Bone loss in SMART study
26 December 2008. Related: Conference reports, Side effects.
Parathyroid hormone and vitamin D levels in patients using tenofovir
26 December 2008. Related: Conference reports, Side effects.
Haemoglobin A1c (HbA1c) may underestimate glycaemia in patients with diabetes on HIV therapy
26 December 2008. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Statin use in HIV-positive patients
26 December 2008. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
HIV reinfection reported in 10% of couples in Zambian study
26 December 2008. Related: Conference reports, HIV prevention and transmission.
Drug interaction studies with approved drugs
26 December 2008. Related: Conference reports, PK and drug interactions.
FDA approval of generic ARVs
26 December 2008. Related: Treatment access.
Non alcoholic fatty liver disease (NAFLD) is common among HIV-positive patients
26 December 2008. Related: Conference reports, Antiretrovirals.
FDA approves new paediatric AZT dosing
26 December 2008. Related: Antiretrovirals.
US revisions to darunavir label include once-daily indication for naive patients
26 December 2008. Related: Antiretrovirals.
Baseline renal insufficiency and mortality risk in HIV-positive adults in Zambia
26 December 2008. Related: Antiretrovirals.
Inflammatory and coagulation biomarkers linked to mortality in large treatment interruption trial
26 December 2008. Related: Antiretrovirals.
Single high dose fluconazole for oropharyngeal candidiasis
26 December 2008. Related: Coinfections and complications.
IAS USA resistance guidelines (2008)
26 December 2008. Related: Guidelines.
BHIVA guidelines for immunisation of HIV-infected adults (2008)
26 December 2008. Related: Guidelines, BHIVA news.
2008 European Guidelines (EACS) online
26 December 2008. Related: Guidelines.
US guidelines updated – November 2008
26 December 2008. Related: Guidelines.
OCTANE Trial DSMB finds ritonavir-boosted lopinavir superior to nevirapine in HIV-positive women previously exposed to single dose nevirapine
26 December 2008. Related: Pregnancy.
Antiretroviral therapy in pregnant women and pregnancy outcomes in Abidjan, Cote D’Ivoire
26 December 2008. Related: Pregnancy.
Key papers on methadone and ritonavir
26 December 2008. Related: PK and drug interactions.
Antiretroviral therapy in HIV-positive children in Southern Africa
26 December 2008. Related: Paediatric care.
Control of a superinfecting virus in an elite controller
26 December 2008. Related: Basic science and immunology.
Second-oldest HIV-1 sequence identified
26 December 2008. Related: Basic science and immunology.
Why do we not yet have an HIV vaccine?
26 December 2008. Related: Basic science and immunology.
Nobel Prize for medicine awarded to French discoverers of HIV
26 December 2008. Related: Other news.
Chinese AIDS activist wins human rights prize
26 December 2008. Related: Other news.
Abstracts from the 9th International Congress on Drug Therapy in HIV Infection
26 December 2008. Related: On the web.
Abstracts from AIDS Vaccine 2008
26 December 2008. Related: On the web.
Abstracts from BHIVA Autumn Conference, 9-10 October 2008
26 December 2008. Related: On the web.
Volume 9 Number 11/12 November/December 2008 PDF
21 December 2008. Related: PDFs.
Volume 9 Number 9/10 Sep/Oct 2008
30 October 2008. Related: Editorial.
17th International AIDS Conference, 3-8 August 2008, Mexico City
30 October 2008. Related: Conference reports.
Abacavir and heart disease: SMART study supports an abacavir-associated increased risk of cardiovascular disease
30 October 2008. Related: Conference reports, Antiretrovirals, Side effects.
HAART use in pregnancy and preterm delivery and low birth weight
30 October 2008. Related: Conference reports, Pregnancy.
Reasons for mother to child transmission in England
30 October 2008. Related: Conference reports, Pregnancy.
New paediatric formulations of ARVs
30 October 2008. Related: Conference reports, Paediatric care.
3rd International Transmission Workshop, 1-2 August 2008, Mexico City
30 October 2008. Related: Conference reports.
Intermittent tenofovir/FTC PrEP offers monkeys some protection
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Tenofovir/FTC gel protects female monkeys from SHIV
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Recently infected HIV-positive Quebec residents cause more than half of new cases
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Common estimate of heterosexual HIV transmission risk sometimes far too low
30 October 2008. Related: Conference reports, HIV prevention and transmission.
US cancel phase 3 HIV vaccine trial
30 October 2008. Related: Basic science and immunology, Vaccines and microbicides.
Detained Chinese AIDS activist quietly sentenced during Olympics
30 October 2008. Related: Other news.
Free The Iranian HIV/AIDS Doctors!
30 October 2008. Related: Other news.
Brazil rejects Gilead patent on tenofovir
30 October 2008. Related: Treatment access.
PEPFAR bill may lift US HIV travel and residency ban
30 October 2008. Related: Treatment access.
Opportunity for doctor to work in Thailand
30 October 2008. Related: Other news.
EMEA state that animal studies support no increased risk of malignancy from contamination of nelfinavir (Viracept) with ethyl mesilate (EMS)
30 October 2008. Related: Antiretrovirals, Side effects.